Loading clinical trials...
Loading clinical trials...
The objective of this protocol is to perform a safety and dose-determination efficacy clinical trial in patients having a degree of partial-thickness burn wounds. The trial will be a prospectively ran...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Noveome Biotherapeutics, formerly Stemnion
NCT06162052 · Burns
NCT06596434 · Burns, Second Degree Burn, and more
NCT06814717 · Thermal Burns
NCT07312513 · Diabetic Ulcers, Arterial Ulcers, and more
NCT07277166 · Burns, Gait Dysfunction, and more
University of South Alabama Dept. of Surgery
Mobile, Alabama
LAC - USC Medical Center
Los Angeles, California
Shands Burn Center at the University of Florida
Gainesville, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions